For 80 years the Department of Psychiatry has provided the highest quality care to adults, children and adolescents, along with pioneering research and education.
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital is thrilled to announce the launch of our newest initiative, ALS MyMatch, an innovative, early phase, biomarker-driven clinical trial network program.
The study found that mutations to VPS35, a key player in this pathway, can prevent chemotherapy-induced cell death. These results, published in Nature, could help pinpoint treatment-resistant tumors.
Researchers investigated sex differences in Alzheimer’s disease (AD) and acute ischemic stroke (AIS), to articulate how they can accelerate research in this area, turn potential pitfalls into solutions, and discover promising avenues for future research.
Researchers used computer modeling to evaluate the potential clinical impact and cost-effectiveness of administering long-acting, injectable antibodies to infants from birth to prevent HIV infection during breastfeeding.
Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, “Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.”
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital is thrilled to announce the launch of our newest initiative, ALS MyMatch, an innovative, early phase, biomarker-driven clinical trial network program.
The study found that mutations to VPS35, a key player in this pathway, can prevent chemotherapy-induced cell death. These results, published in Nature, could help pinpoint treatment-resistant tumors.
Researchers investigated sex differences in Alzheimer’s disease (AD) and acute ischemic stroke (AIS), to articulate how they can accelerate research in this area, turn potential pitfalls into solutions, and discover promising avenues for future research.
1of
6
Innovation in Psychiatry
Neuroscience Advances in Motion is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in psychiatry, neurology and neurosurgery.